People

Executive Chairman Named at JenaValve JenaValve Technology Inc. has attracted the CEO of Laguna Hil

Executive Chairman Named at JenaValve
JenaValve Technology Inc. has attracted the CEO of Laguna Hills, Calif.-based Vessix Vascular Inc. to serve as its new executive chairman of the board. Raymond W. Cohen joins the Munich, Germany-based company with 25 years of medical device industry experience. JenaValve is a venture-backed developer of transcatheter-delivered aortic valve systems (TAVI) for the treatment of aortic valve disease. The company’s U.S. offices are located in Wilmington, Del.

Cohen has served as Vessix’s CEO since 2010. The company, which developed a percutaneous radiofrequency balloon catheter renal denervation system used to treat uncontrolled hypertension, was acquired by Boston Scientific Corporation in November 2012 for $425 million.

Michael J. Dormer will transition from his position as JenaValve’s non-executive chairman of the board of directors to an advisory role. Cohen currently serves as a member of the board of directors of numerous public and private U.S.-based companies.


Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters